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Superoxide dismutase 1 (SOD1) knockout (Sod1−/−) mice exhibit an accelerated aging
phenotype. In humans, SOD1 mutations are linked to familial amyotrophic lateral
sclerosis (ALS), and post-translational modification (PTM) of wild-type SOD1 has been
associated with sporadic ALS. Reversible acetylation regulates many enzymes and
proteomic studies have identified SOD1 acetylation at lysine 123 (K123). The function
and distribution of K123-acetylated SOD1 (Ac-K123 SOD1) in the nervous system is
unknown. Here, we generated polyclonal rabbit antibodies against Ac-K123 SOD1.
Sod1 deletion in Sod1−/− mice, K123 mutation or preabsorption with Ac-K123 peptide
all abolished antibody binding. Using immunohistochemistry, we assessed Ac-K123
SOD1 distribution in the normal adult mouse nervous system. In the cerebellum,
Ac-K123 SOD1 staining was prominent in cell bodies of the granular cell layer (GCL) and
Purkinje cell dendrites and interneurons of the molecular cell layer. In the hippocampus,
Ac-K123 SOD1 staining was strong in the fimbria, subiculum, pyramidal cells and
Schaffer collateral fibers of the cornus ammonis field 1 (CA1) region and granule and
neuronal progenitor cells of the dentate gyrus. In addition, labeling was observed in the
choroid plexus (CP) and the ependyma of the brain ventricles and central canal of the
spinal cord. In the olfactory bulb, Ac-K123 SOD1 staining was prominent in axons of
sensory neurons, in cell bodies of interneurons and neurites of the mitral and tufted cells.
In the retina, labeling was strong in the retinal ganglion cell layer (RGCL) and axons of
retinal ganglion cells (RGCs), the inner nuclear layer (INL) and cone photoreceptors of the
outer nuclear layer (ONL). In summary, our findings describe Ac-K123 SOD1 distribution
to distinct regions and cell types of the normal nervous system.
Keywords: SOD1, acetylation, neurons, cerebellum, hippocampus, ventricle, olfactory bulb, retina
Abbreviations: Ac-K123 SOD1, lysine 123-acetylated SOD1; Ac-peptide, acetylated K123 peptide; AD, Alzheimer’s disease;
ALS, amyotrophic lateral sclerosis; BC, basket cells; CA1, cornus ammonis field 1; CA3, cornus ammonis field 3;
CC, corpus callosum; CP, choroid plexus; CSF, cerebrospinal fluid; ECL, enhanced chemiluminescence; ELISA, enzyme-
linked immunosorbent assay; FBS, fetal bovine serum; GCL, granular cell layer; GFAP, glial fibrillary acidic protein; HDAC,
histone deacetylase; INL, inner nuclear layer; IPL, inner plexiform layer; IPTG, isopropyl β-D-1-thiogalactopyranoside; K123,
lysine 123; LB, Luria Bertani broth; LOT, lateral olfactory tract; MCL, mitral cell layer; ML, molecular layer; NA, numeric
aperture; NAM, nicotinamide; OCT, optimal cutting temperature; ONL, outer nuclear layer; OPL, outer plexiform layer;
PBS, phosphate buffered saline; PCL, Purkinje cell layer; PTM, post-translational modification; RGCL, retinal ganglion cell
layer; SC, stellate cells; SDS, sodium dodecyl sulfate; SLM, stratum lacunosum-moleculare; SOB, Super Optimal Broth; SOD1,
superoxide dismutase 1; SOD1 K123Q, acetyl-mimetic mutant of SOD1; SOD1 K123R, deacetyl-mimetic mutant of SOD1;
SP, stratum pyramidale; SR, stratum radiatum; TSA, trichostatin A.
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INTRODUCTION
Superoxide dismutase 1 (SOD1) is an antioxidant enzyme
that converts superoxide radicals to hydrogen peroxide and
oxygen (McCord and Fridovich, 1969). SOD1 is a predominantly
cytoplasmic enzyme that is ubiquitously expressed, conserved
across species and abundant in most cell types of the nervous
system (Crapo et al., 1992; Pardo et al., 1995). Sod1 knockout
(Sod1)mice exhibit various aging phenotypes that include retinal
degeneration and vision loss, cochlear hair cell degeneration and
hearing loss, accelerated motor neuron degeneration after axonal
injury and exacerbated memory loss and amyloid deposition
when crossed to a mouse model of Alzheimer’s disease (AD),
raising the possibility that SOD1 may play an important
neuroprotective role (Behndig et al., 2001; Imamura et al., 2006;
Hashizume et al., 2008;Murakami et al., 2011, 2012; Kojima et al.,
2012; Saccon et al., 2013).
Mutations in the human SOD1 gene1 cause familial
amyotrophic lateral sclerosis (ALS), a neurodegenerative
disorder of motor neurons (Rosen et al., 1993). However,
oxidation of SOD1 has also been linked to sporadic ALS
(Rakhit et al., 2002), indicating that specific post-translational
modifications (PTMs) of the wild-type protein may contribute
to late-onset disease. Glutathionylation, palmitoylation and
succinylation are among the characterized PTMs of SOD1
(Redler et al., 2011; Antinone et al., 2013; Lin et al., 2013).
Several proteomic studies have also identified acetylation at
conserved lysine 123 (K123; Choudhary et al., 2009; Zhao
et al., 2010; Yang et al., 2011; Lundby et al., 2012; Weinert
et al., 2013). K123 maps to the electrostatic loop of SOD1,
a region required for copper binding, protein folding and
substrate recruitment (Crapo et al., 1992; Pardo et al., 1995).
Lysine acetylation is a reversible PTM that regulates the
interaction, subcellular localization, folding and activity of
many proteins (Kouzarides, 2000). The functional effects
of lysine acetylation are wide ranging (Drazic et al., 2016).
Dysregulation of lysine acetylation has been reported in
numerous disorders including neurodegeneration and cancer
(Drazic et al., 2016).
Here, we report the generation of new polyclonal rabbit
antibodies against the K123-acetylated form of SOD1 and
characterize the distribution of Ac-K123 SOD1 in the normal
mouse nervous system.
MATERIALS AND METHODS
Materials
Kanamycin A monosulfate, phosphate buffered saline (PBS), pH
7.4, EDTA, Tubastatin A hydrochloride, gelatin from cold water
fish skin 45% in H2O, Ponceau S solution 0.1% w/v and 5% acetic
acid, SOD assay kit, sodium orthovanadate, CuCl2, ZnSO4•H2O,
poly-L-lysine, Mowiol 4–88 and 1,4-diazabicyclo-[2,2,2]-octane
(DABCO) were obtained from Sigma-Aldrich. Trichostatin A
(TSA) was obtained from Cayman Chemical. Nicotinamide
(NAM) and MgSO47•H2O were obtained was from Fluka
1http://alsod.iop.kcl.ac.uk/
Chemical. Dulbecco’s Modified Eagle Medium (DMEM)
containing 4500 mg/L D-glucose, GlutaMAX-1, One Shot
fetal bovine serum (FBS), Opti-MEM + GltaMAX/reduced
serum medium, N-2 supplement, 100× penicillin-streptomycin
solution, L15 and Earle’s Balanced Salt Solution (EBSS)
were obtained from Gibco by Life Technologies. Bolt LDS
sample buffer, Bolt 4%–12% Bis-Tris Plus polyacrylamide
gels, Bolt MES sodium dodecyl sulfate (SDS) running buffer,
Colloidal Blue staining kit and BL21(DE) competent cells were
obtained from Invitrogen by Thermo Scientific. Premium
cover glass was obtained from Fisher Scientific. Gene Jet
Plasmid Maxiprep kit, Tissue Protein Extraction Reagent
(T-PER), HALTTM protease inhibitor cocktail and HALTTM
phosphatase inhibitor cocktail were obtained from Thermo
Scientific. iBlot Dry Blotting System and iBlot Gel transfer
stacks were obtained from Novex by Life Technologies.
TurboFect transfection reagent was obtained from Fermentas.
Neutralized bacteriological peptone was obtained from Oxoid.
HEPES-free acid, isopropyl β-D-1-thiogalactopyranoside
(IPTG), dithiothreitol (DTT), NaCl and KCl were obtained from
OmniPur/Calbiochem. Sucrose-ultrapure was obtained from
J.T. Baker. Tris-proteomic grade, β-mercaptoethanol-proteomic
grade and Histochoice MB Tissue Fixative were obtained
from AMRESCO. 3-[(3-Cholamidopropyl)dimethylammonio]-
1-propanesulfonate (CHAPS) was obtained from G-Biosciences.
Paraformaldehyde-EM grade, Prill purified was obtained from
Ted Pella, Inc. Optimal Cutting Temperature (OCT) compound,
Tissue-Tek Cryomolds and Accu-Edge low profile microtome
blades were obtained from Sakura. Isoflurane, USP was obtained
from Abbott Laboratories. Ten percent Tween-20 Surfact-Amps
detergent solution, Pierce Coomassie Plus Bradford assay kit,
Pierce enhanced chemiluminescence (ECL) Western Blotting
Substrate, 20 mM Hoechst 33342 solution and Cytoseal
60 were obtained from Thermo Fisher Scientific. QuikChange
Lightning site-directed mutagenesis kit was obtained from
Agilent Technologies. PCR primers for site-directed mutagenesis
were obtained from Integrated DNA Technologies. QIAprep
Spin Miniprep Kit was obtained from Qiagen. Difco Luria
Bertani broth (LB), Lennox, was obtained from Becton,
Dickinson, and Company. Ethanol, agar, yeast extract and
tryptone were obtained from EMD Millipore. Tissue culture
dishes (100 and 145 mm) were obtained from Greiner Bio.
Costar cell scrapers, Falcon polypropylene tubes, 75 cm2
Cellgro culture flasks and 0.25% trypsin were obtained
from Corning Life Sciences. cOmplete Mini, EDTA-free
protease inhibitors were obtained from Roche. Amersham
Hyperfilm ECL high performance chemiluminescence film
and DEAE Sephacel beads were obtained from GE Healthcare
Limited. VECTASHIELD Antifade Mounting Medium was
obtained from Vector Laboratories, Inc. Superfrost Plus
micro slides were obtained from VWR. Twelve millimetre
diameter #1 glass coverslips were obtained from Chemglass Life
Sciences.
Mice and rats
B6;129S-Sod1tm1Leb/J (Sod1−/+), B6126F1/J, (Sod1+/+), DBA/2J
and 129S1/SvlmJ mice were obtained from Jackson Laboratories.
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B6.Cg-Sod1tm1Cje (Sod1−/−) mice were generated as previously
described (Huang et al., 1997). Brain and eye tissue were
collected from three 5-month-old male mice of both DBA/2J
and 129S1/SvlmJ strains. Timed-pregnant Sprague Dawley rats
were purchased from Charles River. All work with animals was
performed in accordance with Institutional Animal Care and
Use Committee (IACUC) of the University of Central Florida
protocols.
Antibodies
Custom polyclonal rabbit antibodies for Ac-K123 SOD1 were
generated by YenZym Antibodies, LLC, by immunization
of two rabbits (R25 and R26) with the peptide VVHE-acK-
ADDLGKGGC (Ac-peptide) of human SOD1119–131 conjugated
to the carrier protein THY. Pre-immune serum, test serum
and final anti-serum were collected and antibody titers were
confirmed by enzyme-linked immunosorbent assay (ELISA).
Acetylation-specific antibodies were purified from anti-sera
using an affinity matrix conjugated with the Ac-peptide. To
eliminate any cross-reactive material, the antibody fraction
was then further purified using a matrix conjugated with
the unacetylated peptide VVHEKADDLGKGGC (peptide).
Purification of the acetylation-specific antibodies was
confirmed using ELISA with the acetylated and unacetylated
peptide.
Commercial mouse monoclonal SOD1 (G-11), rabbit
polyclonal SOD1 (FL-154), goat polyclonal calbindin
D28K (N-18) and goat polyclonal doublecortin (C18)
antibodies were obtained from Santa Cruz Biotechnology,
Inc. Chicken polyclonal glial fibrillary acidic protein (GFAP;
ab4674) antibody and rabbit polyclonal beta-III tubulin
(ab18207) antibody were obtained from Abcam. Mouse
monoclonal α-tubulin (DM1A) antibody was obtained
from Cell Signaling Technology. Mouse monoclonal NeuN
(A60) monoclonal antibody was obtained from EMD
Millipore. Mouse monoclonal K40 acetylated-α-tubulin
(6-11B-1) antibody was obtained from Sigma. Rabbit
polyconal SOD1 (10011387) was obtained from Cayman
Chemical.
Secondary peroxidase-conjugated AffiniPure donkey
anti-rabbit IgG (H + L) peroxidase-conjugated AffiniPure
donkey anti-mouse IgG (H + L), and Alexa Fluor 594 AffiniPure
Fab fragment donkey anti-rabbit IgG (H + L) antibodies were
obtained from Jackson ImmunoResearch Laboratories, Inc.
Goat anti-rabbit IRDye 800CW and goat anti-mouse IRDye
680LT antibodies were obtained from LI-COR. Alexa Fluor
488 goat-anti-rabbit IgG (H + L), highly cross-absorbed,
Alexa Fluor 594 goat anti-mouse IgG (H + L), Alexa Fluor
594-donkey anti-goat IgG (H + L) and Alexa Fluor 647 donkey-
anti-chicken IgG (H + L) were obtained from Molecular
Probes.
Site-Directed Mutagenesis
Mutagenesis was performed using the QuikChange Lightning
site-directed mutagenesis kit. The SOD1 K123Q and
SOD1 K123R mutants for bacterial expression were created
from a pET-3d SOD1WT vector (gift from Dr. Joseph Beckman,
Oregon State University). The EGFP-tagged SOD1-K123R
mutant was created using the mammalian expression vector
pEGFP-C1WT SOD1 as a template (gift from Dr. Kurt J. DeVos,
University of Sheffield). The primers utilized for mutagenesis
were as follows:
Primer Sequence
K123Q Forward 5′-GCACACTGGTGGTCCATGAACAAGCAGATGACTTGGGC-3′
K123Q Reverse 5′-GCCCAAGTCATCTGCTTGTTCATGGACCACCAGTGTGC-3′
K123R Forward 5′-GCACACTGGTGGTCCATGAAAGAGCAGATGACTTGGGC-3′
K123R Reverse 5′-GCCCAAGTCATCTGCTCTTTCATGGACCACCAGTGTGC-3′
The DNA template-primer mix was amplified using an
Eppendorf Mastercycler Gradient 531 PCR machine. After PCR
amplification, template DNA was digested by incubation with
DpnI at 37◦C for 5 min. For bacterial transformation, 22.5 µL
of XL10-Gold Ultracompetent bacteria were incubated with 2µL
of PCR-amplified DNA on ice for 30 min, heat-shocked at
42◦C for 30 s, and placed back on ice for 2 min. Bacteria
were then resuspended in 500 µL pre-warmed super optimal
broth (SOB; 0.5% yeast extract, 2% tryptone, 10 mM NaCl,
2.5 mM KCl, 20 mM MgSO4) and then grown for 1 h at
37◦C in a bacterial shaker at 225 rpm. Finally, 200 µL was
plated on LB kanamycin A (100 µg/mL) agar plates. After
37◦C overnight incubation, single colonies were picked and
inoculated in 5 mL LB medium with kanamycin A (100
µg/mL). Bacterial cultures were grown overnight at 37◦C in
a bacterial shaker at 225 rpm. Plasmid DNA was isolated
using a QIAprep Spin Miniprep kit and subjected to DNA
sequencing to confirm mutagenesis (Eurofins Scientific). Large-
scale endotoxin-free plasmid DNA was isolated using a Gene Jet
Plasmid Maxiprep kit.
Transfection and HEK293 Cell Extracts
HEK293 cells were grown at 5% CO2 and 37◦C in 100 mm
tissue culture dishes with 10 mL growth medium (DMEM
containing 4500 mg/L D-glucose, GlutaMax-1, supplemented
with penicillin/streptomycin and 10% FBS). Transfection was
performed when cells reached ∼80% confluency. pEGFP-C1-
WT or pEGFP-C1 SOD1 mutant plasmid DNA (10 µg)
was mixed with 20 µL TurboFect transfection reagent in
1 mL reduced serum Opti-MEM medium and incubated
for 20 min at room temperature. The DNA/transfection
mixture was then added drop-wise to the cells in growth
medium. After 48 h, the cells were lysed and cell extracts
were prepared. Briefly, the cells were placed on ice and
the growth medium was aspirated and replaced with 5 mL
ice-cold PBS. Cells were removed from the culture dish using
a cell scraper and pelleted by centrifugation at 100× g for
10 min at 4◦C in an Eppendorf 5810R table centrifuge. The
cell pellets were then resuspended in 500 µL of ice-cold
lysis buffer with 50 mM HEPES-Na pH 7.4, 150 mM NaCl,
1 mM EDTA, 2% CHAPS, 2 mM DTT, 1 mM MgCl2,
1 mM NAM, 1 µM TSA, 2 mM sodium orthovanadate and
cOmplete EDTA-free protease inhibitors. After 30 min on ice
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and intermittent vortexing, soluble proteins were cleared by
centrifugation at 18,200× g for 20 min at 4◦C in an Eppendorf
5417R microcentrifuge. Supernatants were saved and protein
concentrations were determined using a Pierce Bradford protein
assay kit.
Deacetylase Inhibition and HEK293 Cell
Extracts
HEK293 cells seeded onto 145 mm culture dishes in 20 mL
growth medium were grown to near confluency and treated
with deacetylase inhibitors (10 mM NAM plus 1 µM TSA)
or a DMSO vehicle control. After a 6-h treatment at 5%
CO2 and 37◦C, cells were harvested as described in 2.5 and
resuspended in ice-cold Tissue Protein Extraction Reagent
(T-PER) supplemented with 200 µM NAM, 10 µM TSA and
HALTTM protease and phosphatase inhibitors at a volume
of 10 mL/g cell pellet. Cells were then subjected to three
freeze/thaw cycles using a dry ice/ethanol bath and 37◦C
water bath followed by one cycle of sonication on ice
(30 s at output 5 and 50% duty cycle) using a Branson
Sonifer 450. Cellular debris was removed by centrifugation
at 18,200× g for 20 min at 4◦C in an Eppendorf 5417R
microcentrifuge. Cleared supernatants were saved and protein
concentrations were determined with a Pierce Bradford protein
assay kit.
Tissue Lysates
Isolated brains from Sod1−/− or Sod1+/+ mice were frozen
and stored at −70◦C. Prior to tissue lysate preparation, brains
were equilibrated to −20◦C for 30 min, minced into small
pieces and 1 g tissue was resuspended in 10 mL ice-cold
T-PER Tissue Protein Extraction Reagent with 200 µM NAM,
10 µM TSA, 10 µM Tubastatin A and HALTTM protease
and phosphatase inhibitors. Following a 30-min incubation
on ice, tissues underwent five cycles of sonication on ice
(20 s at output 5 and 50% duty cycle) using a Branson
Sonifer 450. Tissue lysates were then passed through a
syringe fitted with a 25 1/2 gauge needle until no longer
viscous. Cellular debris was removed by centrifugation at
18,200× g for 30 min at 4◦C in an Eppendorf 5417R
microcentrifuge. Supernatants were collected and protein
concentrations were determined using a Pierce Bradford
assay kit.
Western Blotting
Protein samples (30 µg) were mixed with Bolt LDS sample
buffer and 5% β-mercaptoethanol, heated at 95◦C for 10 min,
and loaded onto a Bolt 4%–12% Bis-Tris Plus gradient
gel. Electrophoresis was carried out using Bolt MES SDS
running buffer and a constant voltage of 120 V. Following
electrophoresis, gels were soaked in ice-cold 20% ethanol
in ddH2O for 10 min. Proteins were then transferred to
nitrocellulose membranes (0.2 µm pore size) using iBlot Gel
transfer stacks and an iBlot Dry Blotting System, program
P3 for 10 min. Transfer efficiency was verified by staining
with Ponceau S 0.1% w/v, 5% acetic acid solution. Membranes
were briefly rinsed with ddH2O to remove the Ponceau S
staining. To block unspecific protein binding, membranes were
incubated with blocking buffer comprising 5% peptone, 1%
gelatin in 20 mM Tris-Cl, pH 7.8, 150 mM NaCl and 0.1%
Tween-20 Surfact-Amps (TBST) for 3 h at room temperature
under constant rocking. Membranes were then rinsed with
TBST and incubated overnight at 4◦C with primary antibodies
diluted in 1% peptone, 1% gelatin in TBST at 1 µg/mL for
rabbit polyclonal Ac-K123 SOD1, 1:5000 for mouse monoclonal
SOD1 (G11), 1:200 for rabbit polyclonal SOD1 (FL-154) and
1:2500 for mouse monoclonal α-Tubulin (DMA1). In antibody
peptide preabsorption controls, Ac-K123 SOD1 antibody was
mixed for 2 h at room temperature in 1% peptone, 1%
gelatin in TBST with either Ac-K123 peptide, K123 peptide
or a mixture of the two peptides. Immediately following
preabsorption, the antibody/peptide mix was used for western
blotting. Following primary antibody incubation overnight,
membranes were washed 5× with 100 mL TBST for 5 min
under rigorous shaking. For ECL western blotting, membranes
were then incubated with secondary peroxidase-conjugated
AffiniPure donkey anti-rabbit IgG (H + L) or peroxidase-
conjugated AffiniPure donkey anti-mouse IgG (H + L) diluted
1:10,000 in 1% peptone, 1% gelatin in TBST for 2 h at
room temperature and then washed 5× with 100 mL TBST
for 5 min. Finally, membranes were rinsed once in TBS and
protein-antibody complexes were visualized using a Pierce
ECL Western Blotting Substrate and exposure to Amersham
Hyperfilm ECL high performance chemiluminescence film.
For infrared fluorescence western blotting, blocking and
primary antibody incubation were carried out as described
above. Secondary goat anti-rabbit IRDye 800CW or goat
anti-mouse IRDye 680LT antibodies were diluted 1:20,000 in
1% gelatin in TBST and incubated light-protected for 2 h
at room temperature under constant rocking. Membranes
were washed 4× with 100 mL TBST and 1× with TBS.
Protein-antibody complexes were then detected by scanning
the membranes using a LI-COR Odyssey 9120 infrared
imaging system. ImageJ software was used for densitometric
analysis and statistical analysis was performed using Prism 6
(GraphPad).
Primary Spinal Cord Astrocytes
Primary astrocytes were isolated from spinal cords of one litter
of E18 embryos from a timed-pregnant Sprague Dawley rat.
Spinal cord tissues were isolated, minced and digested in 0.025%
trypsin in EBSS at 37◦C for 20 min. Tissues were transferred
into a 50 mL tube containing 45 mL pre-warmed astrocyte
medium (DMEM containing 4500 mg/L D-glucose, GlutaMax-1,
N-2 supplement, 10% FBS and penicillin/streptomycin) and
allowed to sink. After tissues settled, medium was removed and
replaced with 10 mL fresh astrocyte medium. Tissues were then
triturated 20 times using a P1000 micropipette and seeded onto
three 75 cm2 Cellgro culture flasks and cultured at 37◦C, 5%
CO2. Medium was replaced the next day and astrocytes were
grown until confluent. Upon reaching confluency, astrocytes
were trypsinized with 0.25% trypsin and seeded at 2 × 105
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cells/cm2 onto 12 mm diameter #1 glass coverslips coated with
poly-L-lysine (50 µg/mL in ddH2O). Prior to immunostaining,
confluent astrocytes were treated for 5 h with either deacetylase
inhibitors (10 mM NAM, 1 µM TSA) or DMSO vehicle
control.
Immunocytochemistry
Astrocytes grown on glass coverslips were fixed in freshly
prepared 4% paraformaldehyde in PBS pH 7.4 for 10 min at
room temperature followed by three 5-min PBS washes. Fixed
cells were permeabilized with 0.10% Triton X-100 in PBS for
10 min. Cells were then washed with PBS three times for 5 min.
Blocking was performed by incubating fixed cells with 1% fish
gelatin in PBS for 30 min at room temperature. Incubation with
primary antibodies was performed in 1% fish gelatin in PBS
at 4◦C overnight in a humidified chamber. Primary antibodies
included rabbit polyclonal Ac-K123 SOD1 R26 (1 µg/mL)
and rabbit polyconal SOD1 (10011387; 1:2000). In antibody
preabsorption controls, Ac-K123 SOD1 antibody was mixed
for 2 h at room temperature in 1% cold fish gelatin in PBS
with either Ac-peptide, unacetylated peptide or a mixture
of the two peptides. Immediately following preabsorption,
the antibody/peptide mix was used for immunocytochemical
staining. Following primary antibody incubation, coverslips
underwent three 5-min PBS washes. Goat-anti-rabbit Alexa
Fluor 488 conjugated secondary antibody diluted 1:250 in
1% fish gelatin in PBS was then applied to coverslips for
1 h at room temperature within a humidified chamber.
Nuclei were stained with 1 µg/mL Hoechst 33342 in PBS
for 10 min. Coverslips underwent three 5-min PBS washes
and were mounted onto VECTASHIELD Antifade Mounting
Medium and sealed onto glass slides with Cytoseal 60. Mean
fluorescence intensity measurements were made with ImageJ
software and statistical analysis was performed using Prism 6
(GraphPad).
Tissue Embedding
Tissues were collected following the guidelines of the IACUC.
To isolate retinas, 129S1/SvlmJ mice were sacrificed by a lethal
dose of isoflurane. Eyes were removed and radial cuts were made
in the cornea to remove the lens. The isolated eye cups were
then fixed in 4% paraformaldehyde, 5% sucrose, in PBS, for
15 min at room temperature. Retinas were then isolated and
fixed for an additional 45 min in 4% paraformaldehyde, 5%
sucrose, in PBS. After fixation, the retinas were rinsed 3× for
10 min with 5% sucrose and then 10% sucrose in PBS. Finally,
the retinas were kept in 20% sucrose in PBS overnight at 4◦C.
For tissue embedding, retinas were incubated for 30 min in 100%
OCT, followed by 30 min in one part 20% sucrose in PBS to
two parts OCT, and then 30 min in two parts 20% sucrose in
PBS to one part OCT. Finally, the retinas were embedded in
two parts 20% sucrose in PBS to one part OCT in Tissue-Tek
Cryomolds (25 mm× 20 mm× 5 mm) using a dry ice/2-methyl
butane bath after the boiling stopped. Brains and spinal cords
from 129S1/SvlmJ or DBA2/J mice were processed in the same
manner, except that final embedding was performed in 100%
OCT. Unfixed brains of Sod1+/+ and Sod−/− mice were stored
at −70◦C and directly embedded in 100% OCT as described
above.
Cryostat Sectioning
Before cryosectioning, frozen tissue blocks were equilibrated
to the cutting temperature for at least 1 h in the chamber
of a Leica CM 1850 cryostat. Sections of 8−12 µm were
obtained using a low profile microtome blade at −20◦C to
−22◦C. Tissue sections were collected on Superfrost Plus
micro slides, air-dried using a desiccator for 1 h at room
temperature and stored at −70◦C under desiccant until used for
immunohistochemistry.
Immunohistochemistry
Tissue sections were removed from −70◦C and air-dried for
30 min at room temperature. Sections were rehydrated in PBS
for 10 min at room temperature. Sections from Sod1−/− and
Sod1+/+ mice were fixed in 4% paraformaldehyde in PBS for
10 min at room temperature, followed by three 10-min washes
with PBS. Sections were then permeabilized for 15 min in 0.1%
or 0.15% Triton X-100 in PBS, followed by three 5-min washes
in PBS, and incubated in blocking buffer 2% gelatin, 2% FBS in
PBS for 60 min at room temperature. Primary antibodies were
diluted in 1% gelatin in PBS at 1 µg/mL for rabbit polyclonal
Ac-K123 SOD1, 1:50 for goat polyclonal calbindin D28K,
1:200 for goat polyclonal doublecortin C18, 1:250 for chicken
polyclonal GFAP, 1:1000 for mouse monoclonal NeuN A60 and
1:20,000 for mouse monoclonal Ac-K40 α-tubulin (6-11B-1) and
incubated overnight at 4◦C in a humidified chamber. Negative
controls included primary Ac-K123 SOD1 antibody omission,
pre-immune serum incubation or antibody preabsorption
with the Ac-K123 peptide used for immunization. Excessive
primary antibody binding was removed by 5-min washes in
PBS at room temperature. Secondary antibody Alexa Fluor
488-conjugated goat anti-rabbit IgG (H + L), Alexa Fluor
594-conjugated goat anti-mouse IgG (H + L), Alexa Fluor
594-conjugated donkey anti-goat IgG (H + L), Alexa Fluor
647-conjugated goat anti-chicken IgG (H + L) or Alexa Fluor
594-conjugated Fab Fragment donkey anti-rabbit IgG were
diluted 1:200 in 1% gelatin in PBS and incubated with the
sections for 2 h at room temperature in a humidified chamber
protected from light. Excessive secondary antibody binding
was removed by two 5-min washes with PBS. Nuclei were
stained by incubation with 1 µg/mL Hoechst 33342 in PBS for
10 min followed by two 5-min washes with PBS. Finally, the
sections were mounted with either VECTASHIELD Antifade
MountingMedium orMowiol medium containing 2.5%DABCO
using glass coverslips. Glass slides were sealed with Cytoseal
60 and stored at 4◦C protected from light until proceeding to
microscopy.
Microscopy and Image Analysis
Imaging was carried out with a Zeiss LSM 710 Inverted Axio
Observer confocal laser scanning microscope with six laser
excitation lines (405, 458, 488, 514, 543 and 633 nm), a
34 channel QUASAR detector for spectral analysis, and several
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objectives including a EC Plan-Neofluar 10 × 0.3 numeric
aperture (NA) air objective, Plan-Apochromat 20 × 0.8 NA air
objective, EC Plan-Neofluar 40 × 1.3 NA oil objective and a
Plan-Apochromat 63 × 1.4 NA oil objective. Image acquisition
and processing were performed using Zen 2012 software from
Zeiss. To visualize Hoechst 33342, the excitation/emission
wavelength was 405/495 nm using the diode laser. For Alexa
Fluor 488, the excitation/emission wavelength was 488/540 nm
using the multiline argon laser. For Alexa Fluor 594, the
excitation/emission wavelength was 543/660 nm using a diode
pumped solid state laser plus a QUASAR detector for all emission
wavelengths. On average 25 z-stacks of 0.5 µm step-size were
acquired for 354 µm × 354 µm scaled image size. The z-stacks
were maximally projected and the gamma value adjusted to
0.70−0.85 using the ZEN 2012 software.
Montage images were acquired using a Zeiss Axiovert
Zeiss 100M fluorescence microscope with a Plan-Neofluar
10 × 0.3 NA or Plan-Neofluar 20 × 0.5 NA air objective
(Zeiss), a DG-4/ Xe-arc illumination unit (Sutter Instruments),
a BioPrecision 2 linear encoded XY-motorized stage operated by
a MAC 5000 modular control system (Ludl), and a Sensicam QE
CCD camera (PCO AG) controlled by MetaMorph 7.1 software
(Molecular Devices). To visualize Ac-K123 SOD1- Alexa
488, the excitation filter was S490/20× (Chroma) and the
emission filter was S528/38 m (Chroma). To generate the
montage, the ‘‘scan slide’’ function in Metamorph 7.1 was
used. At each z position in the scan slide area, a three
dimensional image was acquired using the ‘‘stream Z’’
module, generating an average of 100−400 image tiles
(1 × 1 binning, 4 µm step size, 11 z-planes). The z-stacks
were processed in MetaMorph 7.5 using the ‘‘remove haze’’
function and maximally projected. Finally, the montage was
stitched with a 10% image overlay using the ‘‘make montage’’
function.
Bacterial Expression of Human
SOD1 Protein
BL21 (DE3) E. coli competent cells were transformed with
pET-3d SOD1 WT, pET-3d SOD1 K123R or pET-3d
SOD1 K123Q DNA by heat shock. Briefly, DNA (50 ng)
was added to 100 µL of competent cells in pre-chilled Falcon
polypropylene tubes and incubated on ice for 30 min. Heat
shock was then performed in a 42◦C water bath for 45 s followed
by a 2-min incubation on ice. Transformed bacteria were then
resuspended in 1 mL SOC medium and grown at 37◦C for 1 h
while shaking at 225 rpm. One hundred micro litre of bacterial
suspension was then plated onto LB agar plates containing 100
µg/mL ampicillin and grown overnight at 37◦C. Colonies were
rinsed off the agar plates using 5 mL LB medium and used to
inoculate a 1 L flask containing 250 mL LB media with 100
µg/mL ampicillin. Bacteria were then grown at 37◦C while
shaking at 225 rpm until OD600 values reached between 0.4 and
0.6. Protein expression was induced with 1 mM IPTG and grown
for 3 h at 23◦C with shaking at 150 rpm. At the time of induction
of protein expression, cultures were supplemented with 0.05 mM
CuCl2 and 0.1 mM ZnSO4•H2O.
Purification of Human SOD1 from Bacteria
Transformed BL21 (DE3) E. coli expressing WT, K123R or
K123Q mutant of human SOD1 as described in 2.15 above
were collected by centrifugation at 4000× g for 10 min.
Cell pellets were resuspended in 20 mM Tris-HCl pH 8 at
5 mL per gram and lysed by three quick freeze/thaw cycles
using a dry ice/ethanol bath and 37◦C water bath followed
by three cycles of sonication (30 s at output 5 and 50%
duty cycle) on ice. Lysates were cleared by centrifugation
at 18,000× g for 20 min at 4◦C and supernatants were
then transferred to DEAE Sephacel columns where they were
allowed to bind overnight at 4◦C. SOD1 was eluted by NaCl
gradient, starting at 0 mM NaCl and ending at 200 mM
NaCl in 20 mM Tris-HCl pH 8.0. Collected fractions were
evaluated by SDS-PAGE using a Colloidal Blue staining kit, and
SOD1-containing fractions were combined and quantified by
Bradford assay.
Superoxide Dismutase Activity
To measure dismutase activity of human SOD1 WT, K123R and
K123Qmutant protein expressed in bacteria, a SOD assay kit was
used following manufacturer’s instructions.
RESULTS AND DISCUSSION
SOD1 Deletion Abolishes Antibody Binding
To investigate the role of K123 acetylation of SOD1, we generated
polyclonal rabbit antibodies. Two rabbits (R25 and R26) were
immunized with the Ac-peptide representing SOD1119–131.
Acetylation-specific antibodies were purified from anti-sera
using an affinity matrix conjugated with the Ac-peptide
used for immunization. To test whether the antibodies were
specific for SOD1 and lacked cross-reactivity with unrelated
proteins, brain tissue lysates of Sod1+/+ and Sod1−/− mice
were separated by SDS-PAGE and western blot membranes
were probed with primary antibodies for Ac-K123 SOD1, total
SOD1 or α-tubulin. Protein bands were identified using the
ECL detection system. The Ac-K123 SOD1 antibodies detected
a single protein band corresponding to SOD1 in Sod1+/+
mice (Figure 1A, left lane). By contrast, Sod1 gene deletion
in Sod1−/− mice abolished Ac-K123 SOD1 antibody binding
(Figure 1A, right lane). Probing with total SOD1 antibodies
confirmed Sod1 gene deletion in Sod1−/− mice and α-tubulin
antibodies demonstrate equal protein loading. The results
indicate that our new antibody is specific to SOD1 and lacks
cross-reactivity with unrelated proteins using western blotting
techniques.
Next, we tested whether our antibody also lacked cross-
reactivity using immunohistochemistry. Brain tissue sections
from Sod1−/− or Sod1+/+ mice were stained with primary
Ac-K123 SOD1 antibodies and secondary Alexa-Fluor
488 conjugated antibodies. Nuclei were stained with Hoechst
33342 dye. Figure 1B shows confocal micrographs of the
cerebellum. In Sod1+/+ mice, our custom antibody stained
cell bodies of the granular cell layer (GCL) and molecular
layer (ML; Figure 1B, top). By contrast, in Sod1−/− mice no
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FIGURE 1 | Superoxide dismutase 1 (SOD1) knockout abolishes lysine 123-acetylated SOD1 (Ac-K123) antibody binding. (A) Western blot of brain tissue
lysates from Sod1+/+ and Sod1−/− mice probed with Ac-K123 SOD1 (R25), SOD1 (FL-154) and α-Tubulin (DMA1) antibodies. (B) Confocal micrographs (scale bar,
200 µm) of Sod1+/+ and Sod1−/− mouse cerebellum sagittal sections showing Ac-K123 SOD1 (R26) immunostaining, nuclear Hoechst 33342 labeling or merged
image. The granular cell layer (GCL) and molecular layer (ML) of the cerebellar cortex are identified. Below each image is a higher magnification confocal micrograph
(scale bar, 10 µm) of the GCL and ML. Insets show a 2.5× zoom of the boxed region.
immunostaining was detected (Figure 1B, bottom). These results
suggest that our custom antibodies are specific to SOD1 and can
be used for immunohistochemistry.
Antibodies Are Specific for
K123-Acetylated SOD1
To examine antibody specificity to the K123 acetylated form
of SOD1, we transfected HEK293 cells with expression
vectors encoding SOD1 WT or the K123R mutant (where
lysine was replaced by an arginine making it resistant to
acetylation). To differentiate from the endogenous protein,
SOD1 was tagged with EGFP. After 48 h of expression,
protein lysates were generated, separated by SDS-PAGE, and
processed by infrared fluorescence western blotting. Transiently
expressed SOD1 bands were easily distinguishable because
endogenous SOD1 has a molecular weight of approximately
16 kDa while EGFP-tagged SOD1 has a molecular weight
of 43 kDa. Infrared images indicated EGFP-SOD1 WT was
recognized by both Ac-K123 SOD1 and SOD1 antibodies,
as demonstrated by the overlapping bands in the merged
image (Figure 2A, left lane). By contrast, the acetyl-
resistant EGFP-SOD1 K123R mutant was recognized by
SOD1 antibodies but not Ac-K123 SOD1 antibodies (Figure 2A,
right lane). Thus, the inability to recognize SOD1 K123R
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FIGURE 2 | Antibodies are specific for K123-acetylated SOD1. (A) Infrared fluorescence western blot analysis of transfected HEK293 cells expressing SOD1
WT-EGFP or SOD1 K123R-EGFP. Ac-K123 SOD1 (R26) rabbit polyclonal antibody was detected by goat anti-rabbit IRDye 800CW (shown in green) and SOD1
(Continued)
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FIGURE 2 | Continued
(G-11) mouse monoclonal antibody was detected by goat anti-mouse IRDye
680LT antibodies (shown in red). (B) Enhanced chemiluminescence (ECL)
western blot of lysates from HEK293 cells (pretreated for 6 h with DMSO
vehicle control or nicotinamide (NAM)/trichostatin A (TSA)) probed with
Ac-K123 SOD1 rabbit polyclonal or SOD1 (G-11) mouse monoclonal
antibodies. Protein bands were detected by ECL. (C) Bar graph of
quantification for Ac-K123 SOD1 densitometry normalized to SOD1. The
acetylation level of NAM/TSA treated cells are plotted relative to vehicle control
cells (n = 3, ∗significance at P < 0.05 by Student’s t-test). (D) Western blot
analysis of protein extracts isolated from NAM/TSA treated HEK293 cells
probed with Ac-K123 SOD1 (R26) antibody that was pre-incubated with either
no peptide, Ac-peptide (1:1 or 1:5 molar ratio), unmodified peptide (1:100 or
1:500) or a mixture of Ac-peptide and unacetylated peptide (1:1:100).
(E) Quantification of the antibody preabsorption western blot results. Ac-K123
SOD1 band intensities were normalized to those of SOD1 and plotted as
percentage of K123 acetylation relative to the antibody alone (n = 3, ∗∗and
significance at P < 0.01 and P < 0.0001 by ANOVA, respectively).
(F) Confocal micrographs (scale bar, 20 µm) of primary spinal cord astrocytes
immunostained with Ac-K123 SOD1 (R26) antibody that was pre-incubated
with either no peptide, Ac-peptide, unacetylated peptide or a mixture of
Ac-peptide and unacetylated peptide (the same molar rations as in 2D); or a
commercial antibody for total SOD1. Hoechst 33342 nuclear labeling and
merged images are also shown. (G) Quantification of antibody preabsorption
immunocytochemistry results. Data are reported as percentage of nuclear
mean fluorescence intensity relative to the antibody alone control of 150
(antibody alone), 100 (Ab + Ac-peptide 1:1), 100 (Ab + Ac-peptide 1:5), 100
(Ab + unacetylated peptide 1:100), 100 (Ab + unacetylated peptide 1:500) and
100 (Ab + Ac-peptide 1:1 + unacetylated peptide 1:100) astrocytes in three
independent experiments (∗∗∗∗significance at P < 0.0001 by ANOVA).
(H) Confocal micrograph (scale bar, 100 µm) of cerebellum immunostained
with Ac-K123 SOD1 (R26) antibody pre-incubated with unacetylated peptide
at 1:5 molar ratio prior to immunohistochemistry. GCL, granular cell layer; ML,
molecular layer. (I) Confocal micrograph (scale bar, 100 µm) of cerebellum
immunostained with Ac-K123 SOD1 (R26) antibody preabsorbed with
Ac-peptide at 1:5 molar ratio prior to immunohistochemistry. GCL, granular
cell layer; ML, molecular layer.
suggests that the antibody is specific to the K123 acetylated
form of SOD1.
Next, because SOD1 is also succinylated at K123 (Lin et al.,
2013), we needed to confirm that our antibody recognized
K123 acetylation and not another PTM. To do this, we
assessed the detection of endogenous SOD1 K123 acetylation
in HEK293 cells treated with either vehicle control or a mix
of two pan-deacetylase inhibitors (NAM/TSA). After 6 h, cells
were lysed and proteins were resolved by SDS-PAGE for
western blot analysis. Vehicle-control treated cells exhibited
a weak signal for Ac-K123 SOD1 (Figure 2B, left lane).
By contrast, deacetylase inhibition dramatically increased the
Ac-K123 SOD1 signal (Figure 2B, right lane). Reprobing
the blot with antibodies for total SOD1 indicated that the
amount of SOD1 was similar in both samples (Figure 2B). To
quantify the results, we performed densitometric analysis of three
independent western blots and observed a four-fold increase in
Ac-K123 SOD1 in deacetylase inhibited cells (Figure 2C). Taken
together, these data support that the increased signal detected in
deacetylase inhibitor treated cells is due to increased Ac-K123
SOD1 levels, and that the antibody recognizes acetylation
of K123.
Similar to other proteins modified by lysine acetylation, only
a small fraction of total SOD1 is predicted to be acetylated
(Choudhary et al., 2014). Therefore, despite affinity purification
(see ‘‘Antibodies’’ Section), it was important to verify the
absence of antibody cross-reactivity with unacetylated SOD1.
To assess any cross-reactivity, we performed western blots of
deacetylase inhibitor treated lysate using antibody that was
pre-incubated with no peptide, acetylated peptide (Ac-peptide),
unacetylated peptide (peptide) or a mixture of Ac-peptide and
peptide. Pre-incubation of the antibody alone resulted in a
strong signal for Ac-K123 SOD1 (Figure 2D, lane 1). As
expected, preabsorption at 1:1 or 1:5 (antibody:Ac-peptide)
molar ratios totally eliminated antibody binding to Ac-K123
SOD1 (Figure 2D, lanes 2, 3). By contrast, pre-incubation
with peptide at 1:100 or 1:500 failed to eliminate antibody
binding (Figure 2D, lanes 4, 5). Finally, pre-incubation with
a mixture of antibody to Ac-peptide to peptide (1:1:100)
also resulted in loss of signal by western blot (Figure 2D,
lane 6). Quantification of three independent western blots using
densitometry confirmed the results (Figure 2E). Combined,
these western blot results confirm antibody specificity to
Ac-K123 SOD1 and demonstrate an absence of cross-reactivity
to unacetylated SOD1.
Next, it was important to show that the antibody does not
cross-react with unacetylated SOD1 using other techniques
such as immunocytochemistry. Therefore, we performed similar
antibody-peptide pre-incubation experiments using rat primary
spinal cord astrocytes. In the antibody alone condition, we
observed immunostaining of Ac-K123 SOD1 antibody in
the nucleus of astrocytes (Figure 2F, column 1). Antibody
incubated with Ac-peptide at 1:1 or 1:5 molar ratio blocked
immunoreactivity (Figure 2F, columns 2, 3). Preabsorption
of antibody with unacetylated peptide at 1:100 or even
1:500 molar ratios failed to eliminate immunoreactivity
(Figure 2F, columns 4, 5). Finally, antibody incubated with
Ac-peptide and unacetylated peptide at 1:1:100 molar ratios
failed to show immunoreactivity (Figure 2F, column 6).
Immunostaining for total SOD1 using a commercial antibody
revealed cytoplasmic SOD1 staining (Figure 2F, column 7).
Quantification of mean fluorescence intensity is shown in
Figure 2G.
Finally, to confirm antibody specificity using
immunohistochemical techniques, we probed cerebellar tissue
sections with Ac-K123 SOD1 antibodies pre-incubated with the
unacetylated peptide or Ac-peptide at 1:5 molar ratios. Tissue
sections probed antibodies pre-incubated with unacetylated
peptide resulted in labeling of cell bodies of the GCL and cell
bodies and processes of the ML (Figure 2H). By contrast,
immunostaining was abolished in tissue sections probed
with antibodies preabsorbed with Ac-peptide (Figure 2I).
Similarly, primary antibody omission or incubation with
pre-immune serum resulted in a lack of staining (Supplementary
Figure 1).
Our finding that Ac-K123 SOD1 was localized to the nucleus
was unexpected, as SOD1 is regarded as a predominantly
cytoplasmic protein. SOD1 translocation to the nucleus has been
previously described (Tsang et al., 2014), but our finding that
nuclear SOD1 is acetylated at K123 is novel. Acetylation of
K123 may play a role in SOD1 targeting or function in the
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nucleus. Of note, the K123 acetylation status did not impact
enzyme activity as purified WT or mutant SOD1 (K123R,
K123Q) all exhibited comparable SOD activities (Supplementary
Figure 2).
In summary, antibody blocking with Ac-peptide prevented
signal detection by western blot, immunocytochemistry of fixed
cells and immunohistochemistry of brain tissue sections. These
findings demonstrate that our custom antibodies are specific to
K123 acetylated SOD1 and lack cross-reactivity to unacetylated
SOD1. For the above reasons, we believe the results obtained
below using this antibody likely reflect authentic Ac-K123
SOD1 in tissue.
Ac-K123 SOD1 Is Found in Granular Cell
Somata and Neurites of the Cerebellum
To investigate the distribution of Ac-K123 SOD1 in the
cerebellum, we immunostained sagittal brain sections. Strong
Ac-K123 SOD1 labeling was detected in the GCL (Figure 3A).
The ML exhibited less intense labeling. A higher magnification
view allowed evaluation of Ac-K123 SOD1 distribution in the
GCL, Purkinje cell layer (PCL), and ML. The most intense
immunostaining was observed in the cell bodies of small, densely
packed glutamatergic neurons of the GCL (Figure 3B). Weak
staining was observed in cell bodies of the PCL. Finally, staining
was also observed in cell bodies and processes extending through
the ML (Figure 3B, inset).
To further examine Purkinje cell staining, tissue was
co-stained with antibodies against calbindin D28K, a Purkinje
cell marker. Previous immunohistological examination
demonstrated that SOD1 was present throughout all cortical
layers of the cerebellum, including cell bodies, dendrites and
axons of Purkinje cells (Thaete et al., 1986; Moreno et al., 1997;
Lindenau et al., 2000). Interestingly, we observed weak Ac-K123
SOD1 labeling within the somata of Purkinje cells compared to
cells of other cortical layers (Figure 3C).
We next focused on the distribution of Ac-K123 SOD1 within
the ML. This outermost layer of the cerebellar cortex comprises
granule cell axons, Purkinje cell dendritic arbors, basket and
stellate cells (SC) interneurons and glial cells. To identify
neurons, sections were co-stained with antibodies against
the neuron-specific class III β-tubulin (Tuj1). We found
Ac-K123 SOD1 localized to the cell bodies of ML interneurons
(Figure 3D). The cerebellar SC, which are located in outer
ML regions and synapse onto the dendritic arbors of Purkinje
cells and basket cells (BC), located immediately above the PCL
and forming elaborate branches around Purkinje cell bodies,
were identified by both location and positive labeling for
Tuj1 (Figure 3D). Labeling was also observed within neuronal
processes extending into the ML, demonstrating Ac-K123
SOD1 distribution to Purkinje cell dendritic arbors and possibly
the axons of granule cells (Figure 3D).
In summary, cerebellar immunostaining demonstrated strong
Ac-K123 SOD1 labeling in the somata of granule cells and ML
interneurons. Purkinje cell bodies exhibited less pronounced
Ac-K123 SOD1 staining, as did neuronal processes extending
into the ML.
Ac-K123 SOD1 Localizes to Hippocampal
Pyramidal Neurons and Granule Cells of
the Dentate Gyrus
Next, we analyzed Ac-K123 distribution within the hippocampus
and dentate gyrus by immunostaining sagittal brain sections
with Ac-K123 SOD1 antibodies. A micrograph montage of the
hippocampal region showed Ac-K123 SOD1 immunostaining
was most prominent in the fimbria and subiculum (Figure 4A).
Within the hippocampus labeling of cornus ammonis field 1
(CA1) was observed, while cornus ammonis field 3 (CA3)
stained less strongly (Figure 4A). Staining was also observed
in the dentate gyrus, the major target of cortical input to the
hippocampus. Cells lining the lateral ventricle and the cortex
were also labeled, and diffuse staining was observed in the corpus
callosum (CC; Figure 4A).
Higher magnification of the hippocampus indicated Ac-K123
SOD1 localization to CA1 stratum pyramidale (SP) cell bodies
and processes within the CA1 stratum radiatum (SR; Figure 4B).
The CA1 SP mostly consists of pyramidal neurons, which
receive input from Schaffer collaterals and send axons to the
subiculum and entorhinal cortex. Also present within this layer,
at a much lower density, are the somata and processes of
local circuit inhibitory interneurons that include axo-axonic,
basket, bistratified and radial trilaminar cells. The CA1 stratum
lacunosum-moleculare (SLM), where performant pathway fibers
from the entorhinal cortex synapse onto apical dendrites of
CA1 pyramidal cells, also exhibited strong labeling (Figure 4B).
Staining was also observed in the dentate gyrus within granule
cells and in cell bodies of the ML and polymorphic layer
(Figure 4B).
We examined the CA1 at higher magnification to assess
labeling of pyramidal neuron cell bodies and processes of the
SR. Co-labeling with antibodies against NeuN, a neuron-specific
marker, confirmed Ac-K123 SOD1 localization to neuronal cell
bodies within the SP (Figure 4C). These labeled cell bodies
are tightly packed and layered in a characteristic pattern for
pyramidal neurons of the hippocampus. A characteristic of
CA1 pyramidal cells is the presence of a single apical dendrite
that branches into secondary oblique dendrites farther away
from the soma. Immunostaining results demonstrated Ac-K123
SOD1 distribution to the apical dendrites extending from
pyramidal neurons into the CA1 SR (Figure 4C). Interestingly,
labeling was not observed in any dendritic branches emanating
from the apical dendrites of pyramidal neurons. Based on the
closely arranged somata in the stratum pryamidale and the
homogenous morphology of processes that extend into the SR,
the observed Ac-K123 labeling within these layers can mostly, if
not exclusively, be attributed to pyramidal neurons.
Next, we assessed immunostaining of the dentate gyrus
granule layer cell bodies at higher magnification. Interestingly,
Ac-K123 SOD1 labeling did not appear to be uniform
(Figure 4D). Because of this uneven Ac-K123 SOD1 staining
pattern of granule cells and the important role of this region in
adult neurogenesis (Ming and Song, 2011), we sought to explore
any possible relationship between Ac-K123 SOD1 and neuronal
development. To examine Ac-K123 SOD1 in cells undergoing
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FIGURE 3 | Ac-K123 SOD1 localization within granule, basket and stellate cells (SC) somata and ML neurites of the cerebellum. (A) Sagittal view
micrograph montage (scale bar, 500 µm) of cerebellum showing Ac-K123 SOD1 (R26) immunostaining within the cerebellar cortex and underlying arbor vitae (Arb).
The cerebellar cortex GCL and ML are noted. (B) Confocal micrograph (scale bar, 50 µm) demonstrating Ac-K123 SOD1 (R26) immunostaining in the cerebellum.
Shown is the cerebellar cortex layers, consisting of the GCL, Purkinje cell layer (PCL) and ML. Inset shows a 2× zoom of the boxed region demonstrating Ac-K123
SOD1 labeled processes within the ML (arrow). (C) Higher magnification confocal micrograph (scale bar, 20 µm) of GCL, PCL and ML immunostained for Ac-K123
SOD1 (R26) and calbindin D28K with nuclear counterstaining by Hoechst 33342. (D) Confocal micrograph (scale bar, 20 µm) of GCL, PCL, and ML immunostained
for Ac-K123 SOD1 (R26) and Tuj1. Examples of SC and basket cells (BC) are marked by arrows.
neurogenesis, brain tissue was co-labeled with antibodies against
doublecortin, a marker for adult neurogenesis. Doublecortin
expression is transient and tapers off in mature neurons (Brown
et al., 2003). Ac-K123 SOD1 immunostaining was strongest in
cell bodies of doublecortin-positive cells of the dentate gyrus
(Figure 4D).
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FIGURE 4 | Distribution of Ac-K123 SOD1 within dentate gyrus granule cells and cornus ammonis field 1 (CA1) hippocampal neurons. (A) Sagittal view
micrograph montage (scale bar, 200 µm) of the hippocampal region immunostained with Ac-K123 SOD1 (R26) antibodies. Areas of interest include the subiculum
(Sub), fimbria (Fim), corpus callosum (CC), cortex (CTX), lateral ventricle (VL), dentate gyrus (DG), hippocampus CA1 and hippocampus CA3 field (CA3). Ac-K123
SOD1 labeling within cells lining the ventricle wall is also shown (arrows). (B) Confocal micrograph (scale bar, 100 µm) of the dentate gyrus and CA1 field of the
hippocampus proper labeled with Ac-K123 SOD1 (R26) antibodies and Hoechst 33342. Dentate gyrus regions include the granule layer (GL), polymorphic layer (PM)
and ML. The CA1 layers shown are the stratum pyramidale (SP), stratum radiatum (SR) and stratum lacunosum-moleculare (SLM). (C) Confocal micrograph (scale
bar, 20 µm) of hippocampus CA1 field pyramidal neurons immunostained with antibodies against Ac-K123 (R26) SOD1 and the adult neuron specific marker NeuN.
(D) Confocal micrograph (scale bar, 20 µm) showing the GL of the dentate gyrus immunostained with antibodies against Ac-K123 SOD1 (R26) and doublecortin.
Immature adult granule neurons are noted (arrows). Insets show a 2.5× zoom of the boxed regions of merged image.
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FIGURE 5 | Ac-K123 SOD1 localization in choroid plexus (CP) and ependymal cells. (A) Sagittal view confocal micrograph (scale bar, 100 µm) of fourth
ventricle immunostained for Ac-K123 SOD1 (R26). Identified are the CP and ventricle wall ependymal cells (E). (B) Higher magnification confocal micrograph (scale
bar, 50 µm) of CP and E immunostained for Ac-K123 SOD1 (R26) and Ac-K40 α-Tubulin. Nuclei were counterstained with Hoechst 33342. (C) Confocal micrograph
(scale bar, 50 µm) of a transverse section of spinal cord immunostained for Ac-K123 SOD1 (R26).
In summary, immunostaining of the hippocampus resulted in
strong Ac-K123 SOD1 labeling of neuronal tracts, including the
subiculum and fimbria. The neurons within the hippocampus
and dentate gyrus, the pyramidal and granule cells, also stained
for Ac-K123 SOD1. CA1 pyramidal cells of the hippocampus
exhibited Ac-K123 SOD1 localization to cell bodies and
dendrites. SOD1 carries out important neuromodulatory
functions within the hippocampus. Secreted SOD1 modulates
synaptic transmission and inhibits long-term potentiation, the
long-lasting form of synaptic enhancement linked to learning
and memory, within the dentate gyrus and CA1 region 1 of the
hippocampus (Knapp and Klann, 2002; Viggiano et al., 2012).
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FIGURE 6 | Ac-K123 SOD1 within the olfactory bulb and lateral olfactory tract (LOT). (A) Confocal micrograph (scale bar, 100 µm) showing Ac-K123 SOD1
(R26) immunostaining, Hoechst nuclear counterstaining and 3× merged image of the posterior main olfactory bulb in the coronal plane. Identified regions include
olfactory nerve layer (ONL), glomerular layer (GL), outer plexiform layer (OPL), mitral cell layer (MCL), inner plexiform layer (IPL) and granule cell layer (GCL).
(B) Confocal micrograph (scale bar, 20 µm) of GL immunostained for Ac-K123 SOD1 (R26). An example of a neurite extending into the glomerulus is also labeled
(arrow). (C) Confocal micrograph (scale bar, 20 µm) of an olfactory glomerulus core within the GL labeled for Ac-K123 SOD1 (R26) and glial fibrillary acidic protein
(GFAP). An example of a neurite labeled with Ac-K123 SOD1 and not GFAP is shown (arrow). (D) Confocal micrograph of the OPL, ML, IPL and GCL immunostained
for Ac-K123 SOD1 (R26; scale bar, 20 µm). Granule cell processes and tufted or mitral cell primary axons are labeled (arrows). (E) Sagittal view confocal micrograph
(scale bar, 100 µm) of posterior olfactory bulb showing axonal tracts extending through the LOT in the area of the olfactory peduncle. Immunostaining of olfactory
bulb was performed with antibodies against Ac-K123 SOD1 (R26) and nuclei were counterstained with Hoechst 33342.
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FIGURE 7 | Ac-K123 SOD1 localization to retinal ganglion cells (RGCs), outer and inner nuclear layer (INL) cell bodies and IPL neurites. (A) Confocal
micrograph (scale bar, 50 µm) of a vertical section through the mouse retina showing Ac-K123 SOD1 (R26) immunostaining with nuclear counterstaining by Hoechst
33342. Identified retinal layers include the inner segments of photoreceptor (IS), outer nuclear layer (ONL), OPL, INL, IPL and retinal ganglion cell layer (RGCL).
(B) Fluorescence micrograph (scale bar, 50 µm) of a vertical section through the mouse retina demonstrating Ac-K123 SOD1 (R26) distribution within RGCL and IPL.
Inset shows a 2× zoom of the boxed region containing a labeled RGC axon.
SOD1 deficiency exacerbates memory loss and amyloid
deposition in a mouse model of AD, and SOD1 levels are
significantly decreased in human AD patients (Murakami
et al., 2011). Thus, it will be interesting to investigate the
potential role of SOD1 acetylation in these processes. Ac-K123
SOD1 was also found in the somata of dentate gyrus granule
cell layer and was highest in doublecortin-positive progenitor
cells.
Ac-K123 SOD1 Is Present in Ependymal
and Choroid Plexus Cells
Recent findings have identified SOD1 in human cerebral
spinal fluid (CSF; Winer et al., 2013). Thus, we sought
to explore whether Ac-K123 SOD1 is present in specific
regions of the brain in contact with CSF. CSF is produced
by the four choroid plexus (CP), branched epithelial
structures found within each ventricle. Analysis of
immunostained sagittal sections demonstrated Ac-K123
SOD1 labeling of CP cells within the 4th ventricle (Figure 5A).
Ac-K123 SOD1 labeling was also observed in ependymal
cells lining the ventricle wall (Figure 5A). A higher
magnification view confirmed strong SOD1 K123 acetylation
within epithelial cells of the CP and ependymal cells
(Figure 5B). Finally, staining was also observed in the
ependymal cells lining the central canal of the spinal cord
(Figure 5C).
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These findings demonstrating Ac-K123 SOD1 distribution
within ependymal cells and the CP epithelia merit further
investigation into the role of SOD1 K123 acetylation in the
regulation of CSF.
Ac-K123 SOD1 Is Present in Interneuron
Cell Bodies and the Major Afferent and
Efferent Neuronal Processes of the
Olfactory Bulb
Olfactory bulb alterations have been observed in mutant
SOD1 transgenic mice (Dal Canto and Gurney, 1995;
Wong et al., 1995). Loss of smell has been observed in
ALS patients and excessive lipofuscin deposition has been
noted in the mitral and tufted cells of their olfactory
bulb (Elian, 1991; Hawkes et al., 1998). We explored
here distribution of Ac-K123 SOD1 within the olfactory
system.
Olfactory bulb coronal sections exhibited strong
Ac-K123 SOD1 antibody staining of the olfactory nerve
layer, the surface of the olfactory bulb formed by afferent
projections of the olfactory sensory neurons (Figure 6A).
Previous immunohistochemical analysis identified high
SOD1 immunoreactivity in olfactory sensory neurons (Yon
et al., 2008), which are responsible for odor detection through
their odorant receptors. Axons from olfactory sensory neurons
project toward the main olfactory bulb, where they synapse
with second-order neurons, the mitral and tufted cells, in
specialized compartments called glomeruli. The glomerular
layer was void of staining with the exception of weak labeling
in the cell bodies surrounding glomeruli (Figure 6A). Beyond
the glomerular layer, Ac-K123 SOD1 staining was observed in
processes spanning the outer plexiform layer (OPL), internal
plexiform layer and granule cell layer (Figure 6A). Cell bodies
of the granule cell layer also exhibited Ac-K123 SOD1 labeling
(Figure 6A).
To better assess Ac-K123 SOD1 staining of the glomerular
layer, we examined this region at higher magnification and
identified Ac-K123 SOD1 distribution within the cell bodies
of periglomerular cells, the small interneurons adjacent to the
glomeruli, and processes within the olfactory glomeruli core
(Figure 6B). These processes are probably neuronal, as they did
not co-label with antibodies against GFAP, an astrocyte marker
(Figure 6C). These Ac-K123 SOD1 positive neurites within the
glomeruli core could be either axons of olfactory sensory neurons
or dendrites of mitral and tufted cells.
A higher magnification view also showed Ac-K123
SOD1 staining of processes in the OPL (Figure 6D). This
layer contains the somata of tufted cells, basal dendrites of
tufted and mitral cells, and apical dendrites of granule cells.
Within the mitral cell layer (MCL), crossing processes showed
strong Ac-K123 SOD1 labeling, while large mitral cell bodies
were weakly stained (Figure 6D). In the internal plexiform
layer, through which axons of mitral and tufted cells course,
staining was observed within processes (Figure 6D). Similar to
the periglomerular interneurons, cells within the granule cell
layer exhibited Ac-K123 SOD1 distribution within their somata
(Figure 6D). These GABAergic granule cells, the principal
interneurons of the olfactory bulb, modulate mitral and tufted
cell activity by inhibitory feedback. In addition to the granule
cell somata, Ac-K123 SOD1 was observed within processes of
the granule cell layer (Figure 6D). Mitral and tufted cells project
axons through this layer, eventually emerging from the caudal
portion of the olfactory bulb to form the lateral olfactory tract
(LOT). These efferent fibers of the LOT connect the olfactory
bulb to several central brain regions via collateral branching
(Schwob and Price, 1984).
A sagittal view of the posterior olfactory bulb identified
Ac-K123 SOD1 within axonal tracts extending through the LOT
in the area of the olfactory peduncle, the region connecting the
olfactory bulb with the basal forebrain. From this view, Ac-K123
SOD1 was also observed in cell bodies of the olfactory bulb
granule cell layer (Figure 6E).
In summary, olfactory bulb immunostaining demonstrated
Ac-K123 SOD1 localization to cell bodies of interneurons and
along processes of the major afferent neurons (olfactory sensory
neurons) and efferent neurons (mitral and tufted cells).
Ac-K123 SOD1 Is Present in Retinal
Ganglion Cells
SOD1 plays a protective role in the retina, an area
particularly susceptible to oxidative stress (Dong et al., 2006).
SOD1 deficiency promotes injury of retinal neurons, and
Sod1−/− mice develop features of retinal degenerative disorders
such as age-related macular degeneration and normal tension
glaucoma (Imamura et al., 2006; Hashizume et al., 2008; Yuki
et al., 2011). We performed immunohistochemical analysis
of frozen mouse retinal tissue sections to compare Ac-K123
SOD1 levels within specific neuronal cells of the retina.
Immunostaining results showed strong Ac-K123
SOD1 detection in the retinal ganglion cell layer (RGCL;
Figure 7A). This layer contains cell bodies of retinal ganglion
cells (RGCs) and displaced amacrine cells. Because Ac-K123
SOD1 exhibited strong localization to both cell bodies and
processes (Figure 7A), we sought out sections with intact
processes to better assess Ac-K123 SOD1 labeling within
the RGCL. Results from selected sections demonstrated
Ac-K123 SOD1 distribution to somata and neurites of
RGCs (Figure 7B). Closer examination of this layer
indicated Ac-K123 SOD1 labeling of RGC axons (Figure 7B,
inset).
Labeling was also observed within somata of the inner nuclear
layer (INL; Figure 7A), which contains the neuronal cell bodies
of bipolar, horizontal and amacrine cells. The somata of Müller
cells, radial glia that span the entire retina, are also found in the
INL. Ac-K123 SOD1 staining was evident within the neuronal
processes of the inner plexiform layer (IPL; Figures 7A,B), the
region between the RGCL and INL that contains the area of
synaptic contact between the bipolar cell axons and the dendrites
of the ganglion and amacrine cells.
The staining of the outer nuclear layer (ONL), which
contains the cell bodies of rods and cones, was strong but
less uniform than that of the RGCL and INL (Figure 7A).
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Because the density of rods is much greater than cones
throughout most of the retina, we surmise that the relatively
sparse number of Ac-K123 SOD1 positive ONL cell bodies
are those of cone cells. This finding is of special interest
because SOD1 is an important component of the antioxidant
defense system of cones (Usui et al., 2011). Weaker Ac-K123
SOD1 labeling was observed in the OPL (Figure 7A), the small
region between the INL and ONL where projections of rods
and cones terminate and synapse with dendrites of bipolar
cells.
In summary, the immunostaining results demonstrated
that Ac-K123 SOD1 was localized to cell bodies within
the INL and RGCL, as well as putative cone cells of
the ONL. Ac-K123 SOD1 was also distributed along
RGC axons and processes coursing through the IPL.
Considering that previous histochemical analysis has shown
diffuse cytoplasmic expression of SOD1 in the retina of
wild-type mice (Imamura et al., 2006; Yuki et al., 2011),
our findings suggest that SOD1 K123 acetylation may be
important to specific cells or regions of the retina. It was
previously shown that SOD1 is indispensable to RGCs and
SOD1 deficiency causes RGC vulnerability and death (Yuki
et al., 2011). SOD1 has also been shown to play an important
neuroprotective role against excitotoxicity in RGCL and
INL cells (Yuki et al., 2013). Because our immunostaining
results indicated high levels of Ac-K123 SOD1 within these
regions, it would be interesting to investigate if there is a
correlation between SOD1 K123 acetylation and retinal neuron
survival.
CONCLUSION
During our investigation of SOD1 K123 acetylation, we
generated rabbit polyclonal antibodies against this PTM
and examined distribution of Ac-K123 SOD1 in the adult
nervous system. In the cerebellum, strongest Ac-K123
SOD1 immunoreactivity was observed in glutamatergic
granule cells. In the hippocampus, the somata of glutamatergic
dentate granule cells and CA1 pyramidal cells were strongly
stained for Ac-K123 SOD1. The strongest Ac-K123
SOD1 labeling of the olfactory bulb was along olfactory
sensory neuron fibers and axons of glutamatergic tufted
and mitral cells. In the retina, the glutamatergic ganglion
cells exhibited the highest levels of Ac-K123 SOD1.
INL cell bodies and glutamatergic ONL cone cells also
exhibited considerable Ac-K123 SOD1 immunoreactivity.
These results suggest that SOD1 K123 acetylation is
largely restricted to specific functionally distinct neuronal
subtypes.
Another key finding was the localization of Ac-K123
SOD1 within processes of major afferent and efferent
neurons. In the hippocampal formation, axonal tracts of
the subiculum and fimbria were strongly labeled, as were apical
dendrites of the efferent CA1 pyramidal cells. Strong Ac-K123
SOD1 labeling was also noted within mitral and tufted cell
axonal projections of the olfactory bulb, along fibers coursing
through the LOT, and in the efferent axons of RGCs. The
propensity of Ac-K123 SOD1 to localize within long axonal
projections of afferent and efferent neurons, as opposed to the
shorter processes of interneurons, merits further study. It is
possible that Ac-K123 SOD1 interacts with proteins specific
to these axons, such as phosphorylated neurofilament heavy
chain proteins, which are predominantly found in larger
axons.
Finally, identification of Ac-K123 SOD1 in cells associated
with CSF is another interesting finding. Ac-K123 SOD1 was
highly localized to CP cuboidal cells and ependymal cells
of the ventricles and central canal, the cells responsible
for CSF production and circulation within the brain and
spinal cord.
Our observations lay the foundation for future investigations
into the role of acetylation in physiology and pathophysiology of
the nervous system.
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